Wednesday, 1 March 2017

Wonkbook: Bernie Sanders takes another swing at big pharma

Sponsored by UnitedHealth Group | By Carolyn Y. Johnson Opening a new front in the war against big pharma, Sen. Bernie Sanders (I-Vt.) and a slew of Democratic colleagues introduced a bill Tuesday to allow commercial importation of drugs from Canada. The appeal is obvious; through cheap imported drugs, the United States would be able to take advantage of the government levers …
 
Wonkbook
The latest economic and domestic policy from Wonkblog
 
 

Sen. Bernie Sanders delivers a speech during J Street's 2017 National Conference at the Washington Convention Center. (Photo by Mark Wilson/Getty Images)

By Carolyn Y. Johnson

Opening a new front in the war against big pharma, Sen. Bernie Sanders (I-Vt.) and a slew of Democratic colleagues introduced a bill Tuesday to allow commercial importation of drugs from Canada.

The appeal is obvious; through cheap imported drugs, the United States would be able to take advantage of the government levers and regulation that other countries have used to bring down pharmaceutical prices. It's a far more politically palatable way to attack the problem of soaring drug prices than opening up an even more contentious fight over whether the U.S. government should meddle directly in pricing — and it has had wide popular and bipartisan support, including from Hillary Clinton and Donald Trump during the presidential campaign.

A drug importation amendment was advanced during the budget resolution vote in the Senate in January. It was rejected, with 13 Democrats voting against the measure. Four of those who voted against the amendment signed on as co-sponsors of the bill.

In an afternoon news conference unveiling the bill, Democratic and independent lawmakers threw down the gauntlet, calling on President Trump — who has repeatedly said that he will do something to rein in rising drug prices — to support their effort.

Read the rest on Wonkblog.


Top Trump tweets

ADVERTISEMENT
 
Most Recent Posts from Wonkblog
Trump may ignore World Trade Organization in major shift of U.S. trade policy
Trump plans a big shift in U.S. trade policy
 
The problem with Trump’s plan to boost Wall Street: Banks are more profitable than ever
The country's nearly 6,000 banks are pulling in even greater profits than they did before the financial crisis when many were benefiting from a hot housing market.
 
Attorney General Sessions wants to know the science on marijuana and opioids. Here it is.
There's been plenty of research done, and scientists desperately want to know more.
 
Bernie Sanders takes another swing at big pharma with bill to allow drug imports
 
ADVERTISEMENT
 
Recommended for you
 
Today's WorldView
What's most important from where the world meets Washington, plus the day's most essential reads and interesting ideas.
Sign Up »
 
     
 
©2017 The Washington Post, 1301 K St NW, Washington DC 20071
 
 
 

No comments:

Post a Comment